XORTX – Therapeutics for Progressive Kidney Disease
Allen Davidoff, PhD, CEO of XORTX Therapeutics, a clinical-stage biotechnology company developing promising therapeutics for progressive kidney disease,...
876 articles
Allen Davidoff, PhD, CEO of XORTX Therapeutics, a clinical-stage biotechnology company developing promising therapeutics for progressive kidney disease,...
Returning guest, Christoph Dankert, SVP of Provider Partnerships at Carrum Health, which offers surgical and cancer care for employee-sponsored health b...
As a Broadway performer living with moderate-to-severe asthma, Tommy Bracco knows how difficult living with the disease can be. Tommy grew up singi...
Shalini Singh, MD, Chief Medical Partner Oncology Network currently serving on the Clinical Development and Medical Affairs leadership team at Roche Dia...
Robert Hoffman, President and CEO at Kintara Therapeutics, a company dedicated to the development of unique anti-cancer therapeutics discusses VAL-083, ...
Craig Eagle, Chief Medical Officer of Guardant Health discusses clinical trial results on colonoscopy effectiveness and why blood-based tests can offer ...
Harvey Kaufman, MD, FCAP, Senior Medical Director, Medical Informatics at Quest Diagnostics, the world's leading provider of diagnostic informatio...
Massachusetts Eye and Ear physician and surgeon, Dr. Learn more on Health Professional Radio.
Jathin Bandari, MD, Chief Medical Officer at Protara Therapeutics, a clinical-stage company committed to identifying and advancing transformative therap...
Nima Farzan, CEO of Kinnate Biopharma Inc., a precision oncology company, discusses the company's investigational targeted cancer therapies which are de...